Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03026192 · ClinicalTrials.gov registry record
Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
A clinical trial, sponsored by Albany Medical College.
- Terminated
- Registry status
- 4
- Enrollment target
NCT03026192 is a clinical trial that was terminated before completion, run by Albany Medical College. The registered enrollment target is 4 participants.
The verdict
NCT03026192 was terminated before completion, sponsored by Albany Medical College.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.
Interventions
- DEVICE near infrared spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-12 |
| Est. Completion | 2018-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03026192
The ClinicalTrials.gov registry entry for NCT03026192 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which near infrared spectroscopy is the first listed.
NCT03026192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03026192 about?
NCT03026192 is a clinical study titled "Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure". Using cerebral and renal near infrared spectroscopy monitoring to determine PDA closure in preterm infants after completing medical treatment for a hemodynamically significant PDA.
What is the current status of trial NCT03026192?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2016-12. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03026192?
The interventions under investigation include: near infrared spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT03026192?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.